{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:28:10Z","timestamp":1773887290236,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jns.2022.120334","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T11:13:00Z","timestamp":1657537980000},"page":"120334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke"],"prefix":"10.1016","volume":"441","author":[{"given":"S.T.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.X.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-Y.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.H.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.jns.2022.120334_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2022.120334_bb0010","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/STROKEAHA.118.024497","article-title":"Antiplatelet therapy after noncardioembolic stroke","volume":"50","author":"Greving","year":"2019","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2022.120334_bb0015","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/STROKEAHA.107.496281","article-title":"Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis","volume":"39","author":"Verro","year":"2008","journal-title":"Stroke"},{"issue":"9523","key":"10.1016\/j.jns.2022.120334_bb0020","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"Halkes","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jns.2022.120334_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1474-4422(09)70361-8","article-title":"Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial","volume":"9","author":"Dengler","year":"2010","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jns.2022.120334_bb0030","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2022.120334_bb0035","series-title":"Phosphodiesterase Inhibitors. Platelets","first-page":"984","author":"Gurbel","year":"2019"},{"issue":"5","key":"10.1016\/j.jns.2022.120334_bb0040","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2141.2010.08539.x","article-title":"Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study","volume":"152","author":"Tobin","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.jns.2022.120334_bb0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/09537104.2015.1049139","article-title":"Platelet function testing in transient ischaemic attack and ischaemic stroke: a comprehensive systematic review of the literature","volume":"26","author":"Lim","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.jns.2022.120334_bb0050","series-title":"P2Y12 Antagonists. Platelets","first-page":"937","author":"Cattaneo","year":"2019"},{"issue":"7","key":"10.1016\/j.jns.2022.120334_bb0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00415-014-7362-3","article-title":"Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke","volume":"261","author":"Tobin","year":"2014","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2022.120334_bb0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1160\/TH04-09-0559","article-title":"Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke","volume":"93","author":"Zhao","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.jns.2022.120334_bb0065","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00415-012-6684-2","article-title":"Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke","volume":"260","author":"Tobin","year":"2013","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2022.120334_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jns.2022.120334_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2022.120334_bb0080","article-title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","volume":"363","author":"Hao","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2022.120334_bb0085","article-title":"Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline","volume":"363","author":"Prasad","year":"2018","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.jns.2022.120334_bb0090","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol."},{"issue":"10123","key":"10.1016\/j.jns.2022.120334_bb0095","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(17)32849-0","article-title":"Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial","volume":"391","author":"Bath","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.jns.2022.120334_bb0100","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"9431","key":"10.1016\/j.jns.2022.120334_bb0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jns.2022.120334_bb0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"SPS 3 Investigators","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jns.2022.120334_bb0115","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1007\/s00415-020-09932-y","article-title":"Platelet function\/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis","volume":"267","author":"Lim","year":"2020","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2022.120334_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clinthera.2008.02.006","volume":"30","author":"Serebruany","year":"2008","journal-title":"Clin. Ther."},{"issue":"9","key":"10.1016\/j.jns.2022.120334_bb0125","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jns.2022.120334_bb0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","author":"European Stroke Organisation Executive Committee","year":"2008","journal-title":"Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.jns.2022.120334_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/09537104.2020.1850670","article-title":"Profile of reticulated platelets in the early, subacute and late phases after transient ischemic attack or ischemic stroke","volume":"33","author":"Lim","year":"2022","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.jns.2022.120334_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jns.2022.120334_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000352050","article-title":"The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping)","volume":"36","author":"Amarenco","year":"2013","journal-title":"Cerebrovasc. Dis."},{"issue":"6","key":"10.1016\/j.jns.2022.120334_bb0150","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.2004.04983.x","article-title":"Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack","volume":"125","author":"McCabe","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.jns.2022.120334_bb0155","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/jth.12277","article-title":"Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets And Carotid Stenosis study","volume":"11","author":"Kinsella","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.jns.2022.120334_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/09537100400020567","article-title":"Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA","volume":"16","author":"McCabe","year":"2005","journal-title":"Platelets"},{"issue":"7","key":"10.1016\/j.jns.2022.120334_bb0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/09537100802317918","article-title":"The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence","volume":"19","author":"van Werkum","year":"2008","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.jns.2022.120334_bb0170","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/01.STR.0000074032.64049.47","article-title":"Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia","volume":"34","author":"Garlichs","year":"2003","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jns.2022.120334_bb0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000228710","article-title":"Leukocyte-platelet aggregates in acute and subacute ischemic stroke","volume":"28","author":"Marquardt","year":"2009","journal-title":"Cerebrovasc. Dis."},{"issue":"8","key":"10.1016\/j.jns.2022.120334_bb0180","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/jnnp-2020-323586","article-title":"Characteristics of ischaemic stroke associated with COVID-19","volume":"91","author":"Beyrouti","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"20","key":"10.1016\/j.jns.2022.120334_bb0185","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of Covid-19 in the young","volume":"382","author":"Oxley","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jns.2022.120334_bb0190","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2022.120334_bb0195","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.jns.2022.120334_bb0200","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2022.120334_bb0205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.jns.2022.120334_bb0210","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","volume":"18","author":"Ranucci","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.jns.2022.120334_bb0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.antiviral.2011.10.019","article-title":"Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods","volume":"93","author":"Steinberg","year":"2012","journal-title":"Antivir. Res."},{"issue":"10","key":"10.1016\/j.jns.2022.120334_bb0220","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/jmv.23354","article-title":"Review: viral infections and mechanisms of thrombosis and bleeding","volume":"84","author":"Goeijenbier","year":"2012","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.jns.2022.120334_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11906-020-01078-6","article-title":"Endothelial dysfunction in COVID-19: lessons learned from coronaviruses","volume":"22","author":"Gavriilaki","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"issue":"17","key":"10.1016\/j.jns.2022.120334_bb0230","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.120.050354","article-title":"Severe COVID-19 is a microvascular disease","volume":"142","author":"Lowenstein","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jns.2022.120334_bb0235","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.15191","article-title":"The ADAMTS13-von Willebrand factor axis in COVID-19 patients","volume":"19","author":"Mancini","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.jns.2022.120334_bb0240","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jns.2022.120334_bb0245","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jns.2022.120334_bb0250","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jns.2022.120334_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.708665","article-title":"Targeting SARS-CoV-2-platelet interactions in COVID-19 and vaccine-related thrombosis","volume":"12","author":"Cox","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.jns.2022.120334_bb0260","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.apsb.2020.04.008","article-title":"Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.jns.2022.120334_bb0265","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.jns.2022.120334_bb0270","doi-asserted-by":"crossref","DOI":"10.2196\/19199","article-title":"Delivering benefits at speed through real-world repurposing of off-patent drugs: the COVID-19 pandemic as a case in point","volume":"6","author":"Rogosnitzky","year":"2020","journal-title":"JMIR Public Health Surveill."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:01:39Z","timestamp":1758384099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":54,"alternative-id":["S0022510X22001964"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120334","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120334"}}